AYTU Historical Earnings image Aytu BioPharma Historical Earnings

This AYTU historical earnings page, which was last updated 6/16/2026, presents historical earnings & revenue information for Aytu BioPharma, presented in both tabular and graphical format for ease of study.
Quick links: Historical Earnings  |  Historical Revenue  |  FAQ
AYTU Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 20265/13/20260.01B
Q2 20262/3/20260.02B
Q1 202611/13/20250.01B
Q4 20259/23/20250.02B
Q3 20255/14/20250.02B
Q2 20252/12/20250.02B
Q1 202511/13/20240.02B
Q4 20249/26/20240.02B
Q3 20245/15/20240.02B
Q2 20242/14/20240.02B
Q1 202411/14/20230.02B
Q4 20239/27/20230.03B
Q3 20235/11/20230.02B
Q2 20232/21/20230.03B
Q1 202311/14/20220.03B
Q4 20229/27/20220.03B
Q3 20225/16/20220.02B
Q2 20222/14/20220.02B
Q1 202211/15/20210.02B
Q4 20219/27/20210.02B
Q3 20215/17/20210.01B
Q2 20212/11/20210.02B
Q1 202111/12/20200.01B
Q4 202010/6/20200.01B
Q3 20205/14/20200.01B
Q2 20202/13/20200.00B
Q1 202011/14/20190.00B
Q4 20199/26/20190.00B
Q3 20195/14/20190.00B
Q2 20192/7/20191.79M
Q4 201811/7/20181.43M
Q3 20185/14/2018607473
Q2 20182/8/20181.05M
AYTU Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 20265/13/2026-0.530
Q2 20262/3/2026-1.050
Q1 202611/13/2025-0.080
Q4 20259/23/2025-0.250
Q3 20255/14/20250.210
Q2 20252/12/2025-0.280
Q1 202511/13/2024-0.200
Q4 20249/26/2024-0.820
Q3 20245/15/2024-0.520
Q2 20242/14/2024-0.040
Q1 202411/14/2023-1.480
Q4 20239/27/2023-0.590
Q3 20235/11/2023-1.930
Q2 20232/21/2023-2.150
Q1 202311/14/2022-1.200
Q4 20229/27/2022-9.800
Q3 20225/16/2022-5.400
Q2 20222/14/2022-8.800
Q1 202211/15/2021-6.600
Q4 20219/27/2021-16.200
Q3 20215/17/2021-8.600
Q2 20212/11/2021-14.000
Q1 202111/12/2020-8.000
Q4 202010/6/2020-4.000
Q3 20205/14/2020-30.000
Q2 20202/13/2020-62.000
Q1 202011/14/2019-64.000
Q4 20199/26/2019-260.000
Q3 20195/14/2019-100.000
Q2 20192/7/2019-144.000
Q4 201811/7/2018-382.000
Q3 20185/14/2018-960.000
Q2 20182/8/2018-3560.000
Quotes delayed 20 minutes

Email EnvelopeFree AYTU Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Aytu BioPharma (AYTU) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

AZRX Historical Earnings
AZYO Historical Earnings
BACK Historical Earnings
BAX Historical Earnings
BBI Historical Earnings
BBIO Historical Earnings
BBLG Historical Earnings
BCAB Historical Earnings
BCDA Historical Earnings
BCEL Historical Earnings
What was the record high AYTU historical earnings result?
In terms of earnings or revenue, what is the best AYTU historical earnings result that Aytu BioPharma has ever posted, and when?

✔️Accepted answer: Within our data set, the highest AYTU historical earnings result was set in Q3 2025, when Aytu BioPharma posted results of 0.210/share. The most successful revenue quarter within our data set was Q4 2023 when Aytu BioPharma reported revenue of 0.03B.

What was the lowest Aytu BioPharma historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest AYTU has reported, and when?

✔️Accepted answer: Within our data set, the lowest AYTU historical earnings result was set in Q2 2018, when Aytu BioPharma posted results of -3560.000/share. The smallest revenue quarter within our data set was Q3 2018 when Aytu BioPharma reported revenue of 607473.

On this page we presented the AYTU historical earnings date information for Aytu BioPharma. Reviewing that AYTU Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2025, when AYTU posted gaap of 0.210/share. Meanwhile the lowest AYTU historical earnings result was in Q2 2018, when AYTU posted gaap of -3560.000/share. Moving to Aytu BioPharmas historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2023 when AYTU reported 0.03B in revenue, while the smallest revenue quarter was Q3 2018 when AYTU reported 607473 in revenue.

For self directed investors doing their due diligence on AYTU or any other given stock, their research can benefit from looking into all of the Aytu BioPharma historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Aytu BioPharma historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for AYTU. Thanks for visiting, and the next time you need to research AYTU historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.
 

AYTU Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2026, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.